Long‐term safety and efficacy of adjunctive lacosamide in the treatment of generalized onset tonic–clonic seizures: An open‐label extension trial

Documenti analoghi

• Long‐term safety and efficacy of adjunctive perampanel in pediatric patients (ages 4 to <12 years) with inadequately controlled focal‐onset seizures or generalized tonic–clonic seizures
  di: Robert Flamini, et al.
  Pubblicazione: (2025)
• The effect of epilepsy surgery on tonic–clonic seizures
  di: Juan Luis Alcala‐Zermeno, et al.
  Pubblicazione: (2025)
• Efficacy and safety of perampanel as first adjunctive therapy in patients with focal‐onset seizures or generalized tonic‐clonic seizures in four post‐marketing studies across regions
  di: Stefano Meletti, et al.
  Pubblicazione: (2025)
• Focal to bilateral tonic–clonic seizures in newly diagnosed focal epilepsy
  di: Shruti Agashe, et al.
  Pubblicazione: (2025)
• Comprehensive scoping review of fenfluramine's role in managing generalized tonic–clonic seizures in developmental and epileptic encephalopathies
  di: Antonio Gil‐Nagel, et al.
  Pubblicazione: (2024)